The coronavirus pandemic has accelerated our cashless society and deepened the divide between those who depend on it and those who now live mostly without it.

  • Plus, President Trump's doubling down on messaging to his base at the exclusion of the broader country spells trouble for him in November.
  • And, the pandemic is causing colleges to cut their sports programs. It's also put pressure on the NCAA to re-examine its reliance on sports for revenue.

Guests: Axios' Jennifer Kingson, Mike Allen and Kendall Baker.

Credits: "Axios Today" is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Sara Kehaulani Goo, Carol Alderman, Cara Shillenn, Naomi Shavin, Nuria Marquez Martinez and Alex Sugiura. Music is composed by Evan Viola. You can reach us at podcasts@axios.com.

Go deeper:

Go deeper

Sep 21, 2020 - Podcasts

What’s next for the Supreme Court

The death of Supreme Court Justice Ruth Bader Ginsburg set off a flurry of activity in Washington this weekend, as hundreds of people who gathered on the court's steps to mourn and politicians mobilized over the fight for her replacement We look at what's next for the court and how both sides of the aisle are thinking about the nomination process.

Updated 28 seconds ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 31,467,508 — Total deaths: 967,881— Total recoveries: 21,583,915Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 6,890,662 — Total deaths: 200,710 — Total recoveries: 2,646,959 — Total tests: 96,612,436Map.
  3. Health: The U.S. reaches 200,000 coronavirus deaths — The CDC's crumbling reputation — America turns against coronavirus vaccine.
  4. Politics: Elected officials are failing us on much-needed stimulus.
  5. Business: Two-thirds of business leaders think pandemic will lead to permanent changes — Fed chair warns economy will feel the weight of expired stimulus.
  6. Sports: NFL fines maskless coaches.
Dan Primack, author of Pro Rata
1 hour ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!